F2RL1 and neoplasm: Consistently, PAR2 plays a dominant part in PAR1–PAR2 instigated tumor activity, since shRNA silencing of hPar2 effectively inhibits PAR1-induced function but silencing hPar1 does not affect PAR2-associated signaling.